Polymerized hemoglobin therapy in a foal with neonatal isoerythrolysis

Journal of Veterinary Emergency and Critical Care

Volumn 11, Issue 2, 2001, Pages 141-146

  Perkins, Gillian A ^a   Divers, Thomas J ^a  

^a Animal Health Diagnostic Center   (United States)

Author keywords

Anemia; Blood tranfusion; Equine; Horse; Neonatal isoerythrolysis; Pa antibody; Polymerized hemoglobin

Indexed keywords

EID: 0003138286     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2001.tb00079.x     Document Type: Article

References (36)

1. Bauer JE. Normal blook chemistry. In: Koterbra AM, Drummond WH, Kosch PC, editors, Equine Clinical Neonatology. Philadelphia :Lea & Febiger, 1990. p. 602–614.
2. Vaala WE. Neonatal anemia. In: Koterbra AM, Drummond WH, Kosh PC, editors, Equine Clinical Neonatology. Philadelphia :Lea & Febiger, 1990. p. 571–588.
3. Carlson GP. Diseases of the hematopoietic and hemolymphatic systems. In: Smith B, editor. Large Animal Internal Medicine, 2nd Ed. St. Louis :Mosby, 1995. p. 1198–1256.
4. Madigan JE, Thomas WP, Backus KQ, Powell WE. Mixed venous blood gases in recumbent and upright positions in foals from birth to 14 days of age. Equine Vet J 1992;24(5):399–401.1992.
5. Brewer BD. Neonatal infection. In: Koterba AM, Drummond WH, Kosch PC, editors. Equine Clinical Neonatology. Philadelphia :Lea&Febiger, 1990. pp. 310.
6. Miller WV, editor. Technical Manual of the American Association of Blood Banks, 7th Ed. Philadelphia:J B Lippincott Co., 1977. p 37–46.
7. Miller E. Immunosuppressive therapy in the treatment of immune-mediated diseases. J Vet Intern Med 1992;6:206–213.
8. Murphy S, LoBuglio AF. Drug therapy of autoimmune hemolytic anemia. Semin Hematol 1976;13:323–334.
9. Rosse W, Bunn HF. Hemolytic anemias and acute blood loss. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Harrison's Principles of Internal Medicine, 14th Ed., vol. 1. New York :McGraw-hill, 1998.p. 659–671.
10. Hudson SD, Ravis WR. Comparative pharmacokinetics of H2 antagonists in horses. Proceedings, 11th Vet Med Forum 1993;11:687–690.
11. Humphries TJ, Merritt GJ. Review article: drug interations with agents used to treat acid-related diseases. Aliment Pharmacol Ther(Suppl) 1999;3:18–26.
12. Sakio H, Ohtsu S, Ueno K. Pathophysiology and strategy of shock in terms of tissue oxygen metabolism. Nippon Geka Gakkai Zasshi 1999;100(10):663–666.
13. Whiting JL, David JB. Neonatal isoerytholysis. Compend Contin Educ Pract Vet 2000;22(10):968–975.
14. Stormont C. Neonatal isoerythrolysis in domestic animals: a comparative review. Adv Vet Sci Comp Med 1975;19:23–45.
15. Becht JL. Neonatal isoerythrolysis in the foal. Part I. Background, blood group antigens, and pathogenesis. Compent Contin Educ Pract Vet 1983;5(11):S591–S598.
16. Bailey E, Conboy S, McCarthy PF. Neonatal isoerythrolysis of foals: an update on testing proceedings, AAEP 1984;33:341–355.
17. Zaeuby JF, Hearn P, Colling D. Neonayal isoerythrolysis in a foal, involving anti-Pa alloantibody. Equine Vet J 1992;24(1):71–73.
18. McClure J, Parrish S. v Diseases Caused by allogenic incompatibilities. Neonata isoerythrolysis. In: Smith B, editor. Large Animal Internal Medicine, 2nd Ed. St. louis : Mosby 1995 P. 1867–1873.
19. Vaala WE. Noninfectious neonatal diseases. In: Equine stud Medicine. sydney post Graduate Foundation in Veterinary Science, Univesity of Sydeny, Australia, 1996. p. 236–241.
20. Goger Um Rentko VT. Alternatives to blood transfusions. Proceedings,16th Vet Med forum 1998; 430–431.
21. Wall RE. Synthertic colloids and blood substitutes. Compend contin Educ Pract Vet 1998; 20(12): S4–9.
22. Hunt E, Wood B. Use of blood and blood products. Bet Clin North Am: Food pract 1999; 15(3): 641–662.
23. Maxon AD, Giger U, SWeeney CT, et al Use of bocine hemoglobin prepartion in the treatment iof cyclic ovarian hemirrhage in a miniature horse. J AM VEt Med ASSoc 1993; 203(9) 1308–1311.
24. Mullon J, Gacoppe G, Clagett C, et al Transfusions iof polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia., N Eng J mMed 2000;342 (22):1638–1643.
25. Rengasamy A, Johns RA. Regulation of nitric oxide synthase by nitric oxide. Mol pharmacol 1993;44(1): 124–148.
26. Ulatowski JA, Koehler RC, Nishikawa T, et al. Role of nitric oxide scavenging in peripheral vasoconstictor response to beta cross-linked hemoglobin. Artif cells Blood Substit Immbobil Biotechnol 1995; 23(3): 263–269.
27. Margulis a, Sitaramayya A. Rate of deactivation of nitric oxide-stimulated solubles and calcium. Biochemistry 2000;39(5): 1034–1039.
28. Loke KE, Forfia PR, Recchia FA, et al Bocine polymerized hemoglobin increases cardiax oxygen consumption and alters myocardial substrate metabolism in conscious dogs: role of nitric oxide. J cardivasc Pharmacol 2000; 35(1): 84–92.
29. Marino PL. The ICU Book, 2nd ED. Baltimore : Williams & Wilkins, 1998. p. 691–708.
30. Hebert PC, Wells G, Blahman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements iin critical care. N Engl J Med 1999; 340(6): 409–417.
31. Cosensus Conference on Periperative red blood cell transfusion. I Am Med Assoc 1988; 260:2700–2703.
32. Practice straytgies for elective red blood cell transufusion. A clinical practice guideline from the American college of Physicians. Ann Intern Med 1992; 116:403–406.
33. LUndsgaard-hansen P, Doran JE, Blauhut B. Is there a generally Valid, minimum acceptable hemoglobin level? Infusionstherapie 1989;16(4): 167–175.
34. Hoffman AM, Staempfli HR, Willan A. Prognostic Variable for survival of neonatasl foals under intensive Care. J Vet Intern Med 1992; 6(2): 89–95.
35. Dnatzker DR. Physiology and pathophysiology of pulmonary gas exchange. Hosp Pract 1986;20(1): 135–157.
36. Rentko VT. Tissue oxygenation via red cells and plasma in the equine patient. Proceeding, 4th International Vet Emerg CRit Care Symposium 2000; 7:701–702.